Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation.

[1]  P. Marynen,et al.  Detection of genomic copy number changes in patients with idiopathic mental retardation by high‐resolution X‐array‐CGH: important role for increased gene dosage of XLMR genes , 2007, Human mutation.

[2]  Song-Yu Yang,et al.  HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids. , 2007, Molecular genetics and metabolism.

[3]  J. Veltman,et al.  High-resolution genomic microarrays for X-linked mental retardation , 2007, Genetics in Medicine.

[4]  Howard Schulman,et al.  Global changes to the ubiquitin system in Huntington's disease , 2007, Nature.

[5]  Pawel Stankiewicz,et al.  Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. , 2007, Current opinion in genetics & development.

[6]  M. Ehlers,et al.  Emerging Roles for Ubiquitin and Protein Degradation in Neuronal Function , 2007, Pharmacological Reviews.

[7]  C. Schwartz,et al.  The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior. , 2007, American journal of human genetics.

[8]  Andrew Menzies,et al.  Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. , 2007, American journal of human genetics.

[9]  S. Grant,et al.  The role of neuronal complexes in human X-linked brain diseases. , 2007, American journal of human genetics.

[10]  S. Korman.  Inborn errors of isoleucine degradation: a review. , 2006, Molecular genetics and metabolism.

[11]  A. Vianna-Morgante,et al.  UBE2A, which encodes a ubiquitin-conjugating enzyme, is mutated in a novel X-linked mental retardation syndrome. , 2006, American journal of human genetics.

[12]  L. Shaffer,et al.  Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. , 2006, The Journal of pediatrics.

[13]  H. Ropers.  X-linked mental retardation: many genes for a complex disorder. , 2006, Current opinion in genetics & development.

[14]  A. Musio,et al.  X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations , 2006, Nature Genetics.

[15]  G Mortier,et al.  Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports , 2006, Journal of Medical Genetics.

[16]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[17]  D. Campion,et al.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy , 2006, Nature Genetics.

[18]  M. Rauh,et al.  Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome) , 2005, Nature Genetics.

[19]  Song-Yu Yang,et al.  3‐Hydroxyacyl‐CoA dehydrogenase and short chain 3‐hydroxyacyl‐CoA dehydrogenase in human health and disease , 2005, The FEBS journal.

[20]  J. Gécz,et al.  Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. , 2005, American journal of human genetics.

[21]  H. Scrable,et al.  Maintaining appearances--the role of p53 in adult neurogenesis. , 2005, Biochemical and biophysical research communications.

[22]  H. Willard,et al.  X-inactivation profile reveals extensive variability in X-linked gene expression in females , 2005, Nature.

[23]  J. Gécz,et al.  Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. , 2005, American journal of human genetics.

[24]  A. Chung,et al.  Over-expression of human UREB1 in colorectal cancer: HECT domain of human UREB1 inhibits the activity of tumor suppressor p53 protein. , 2004, Biochemical and biophysical research communications.

[25]  Ken Inoue.  PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2 , 2005, Neurogenetics.

[26]  Christopher A Ross,et al.  The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases. , 2004, Trends in cell biology.

[27]  M. Vila,et al.  L‐3‐hydroxyacyl‐CoA dehydrogenase II protects in a model of Parkinson's disease , 2004, Annals of neurology.

[28]  R. Wanders,et al.  Spastic diplegia and periventricular white matter abnormalities in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, a defect of isoleucine metabolism: differential diagnosis with hypoxic-ischemic brain diseases. , 2004, Molecular genetics and metabolism.

[29]  M Bobrow,et al.  Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features , 2004, Journal of Medical Genetics.

[30]  J. Gécz.  The molecular basis of intellectual disability: novel genes with naturally occurring mutations causing altered gene expression in the brain. , 2004, Frontiers in bioscience : a journal and virtual library.

[31]  Ton Feuth,et al.  Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. , 2003, American journal of human genetics.

[32]  Daniel Pinkel,et al.  Genomic microarrays in human genetic disease and cancer. , 2003, Human molecular genetics.

[33]  J. Lupski,et al.  Molecular Mechanisms, Diagnosis, and Rational Approaches to Management of and Therapy for Charcot-Marie-Tooth Disease and Related Peripheral Neuropathies , 2003, Journal of Investigative Medicine.

[34]  R. Wanders,et al.  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene. , 2003, American journal of human genetics.

[35]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[36]  H. Leonard,et al.  The epidemiology of mental retardation: challenges and opportunities in the new millennium. , 2002, Mental retardation and developmental disabilities research reviews.

[37]  Ping Fang,et al.  De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome , 1997, Nature Genetics.

[38]  M. Lalande,et al.  UBE3A/E6-AP mutations cause Angelman syndrome , 1996, Nature Genetics.

[39]  A. Donnelly,et al.  Regional localisation of two non-specific X-linked mental retardation genes (MRX30 and MRX31). , 1996, American journal of medical genetics.

[40]  M. Kaufman,et al.  High-frequency developmental abnormalities in p53-deficient mice , 1995, Current Biology.

[41]  J. Mulley,et al.  X-linked mental retardation with heterozygous expression and macrocephaly: pericentromeric gene localization. , 1994, American journal of medical genetics.

[42]  J. Mulley,et al.  Pericentromeric genes for non-specific X-linked mental retardation (MRX). , 1994, American journal of medical genetics.